Emergent Prep for IV Dye in Acute Stroke Patients With Allergy
- Conditions
- Dye AllergyStroke
- Interventions
- Combination Product: Emergent IV Dye Preparation
- First Posted Date
- 2023-06-15
- Last Posted Date
- 2023-06-15
- Lead Sponsor
- Global Neurosciences Institute
- Target Recruit Count
- 50
- Registration Number
- NCT05905900
Verapamil for Neuroprotection in Stroke
Phase 1
Recruiting
- Conditions
- Ischemic Stroke
- Interventions
- Drug: 10 mg Intra-arterial VerapamilDrug: 20 mg Intra-arterial Verapamil
- First Posted Date
- 2017-11-20
- Last Posted Date
- 2025-01-17
- Lead Sponsor
- Global Neurosciences Institute
- Target Recruit Count
- 60
- Registration Number
- NCT03347786
- Locations
- 🇺🇸
AtlantiCare Regional Medical Center, Atlantic City, New Jersey, United States
🇺🇸St Mary Medical Center, Langhorne, Pennsylvania, United States
🇺🇸Crozer Chester Medical Center, Upland, Pennsylvania, United States
Super-Selective Intraarterial Intracranial Infusion of Bevacizumab (Avastin) for Glioblastoma Multiforme
- First Posted Date
- 2014-11-07
- Last Posted Date
- 2022-08-10
- Lead Sponsor
- Global Neurosciences Institute
- Target Recruit Count
- 30
- Registration Number
- NCT02285959
© Copyright 2025. All Rights Reserved by MedPath